Literature DB >> 2851365

Evidence for involvement of an adrenal catecholamine in the beta-adrenergic inhibition of oxytocin release in lactating rats.

S L Song1, W R Crowley, C E Grosvenor.   

Abstract

Adrenergic systems exert dual control over the release of oxytocin (OT) in rats, with stimulation of alpha-adrenergic receptors exciting, and stimulation of beta-adrenergic receptors inhibiting, release of this neurohormone. Because suckling stimulation also releases epinephrine from the adrenal medulla, the present experiments tested whether catecholamines of adrenal origin may participate in the adrenergic regulation of OT release during lactation. In two independent experiments, adrenal demedullation of rats in midlactation did not alter the basal plasma levels of OT, but markedly enhanced the suckling-induced release of OT, suggesting an inhibitory action of an adrenal catecholamine. The OT release induced by suckling in both sham-operated and adrenal demedullated rats was prevented by stimulation of beta-adrenergic receptors with isoproterenol. Conversely, blockade of beta-adrenergic receptors with propranolol prevented the inhibitory effects of isoproterenol, and when given alone, mimicked the effects of demedullation to enhance suckling-induced OT release. Stimulation of peripheral alpha-adrenergic receptors with phenylephrine did not affect either basal or suckling-induced OT release, but blockade of alpha-adrenergic receptors with phentolamine also completely prevented the release of OT by suckling. These data support the concept that stimulation of beta-adrenergic receptors inhibits OT secretion, and further suggest that this may be due, at least in part, to an action of an adrenal catecholamine, which may act centrally and/or directly on the neurohypophysis. The present results also provide further evidence that activation of central, but not peripheral, alpha-adrenergic mechanisms is necessary for suckling-induced OT release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851365     DOI: 10.1016/0006-8993(88)90700-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Activation by serotonin and noradrenaline of vasopressin and oxytocin expression in the mouse paraventricular and supraoptic nuclei.

Authors:  Claire-Marie Vacher; Philippe Frétier; Christophe Créminon; André Calas; Hélène Hardin-Pouzet
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

2.  Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures.

Authors:  Marianna Radács; Andor H Molnár; Ferenc A László; Csaba Varga; Ferenc László; Márta Gálfi
Journal:  J Mol Neurosci       Date:  2010-02-10       Impact factor: 3.444

Review 3.  Oxytocin release in magnocellular nuclei: neurochemical mediators and functional significance during gestation.

Authors:  Steven L Bealer; William E Armstrong; William R Crowley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-16       Impact factor: 3.619

Review 4.  Postpartum Cardiomyopathy and Considerations for Breastfeeding.

Authors:  Laura Kearney; Paul Wright; Sadeer Fhadil; Martin Thomas
Journal:  Card Fail Rev       Date:  2018-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.